Article
Science
(2020)
Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.
FoundryBase
updated about 9 hours ago
Comments
Related Chunks
Related chunks with this resource
Finding a Vaccine for COVID19 Coronavirus - other leading candidates
Finding a Vaccine for COVID19 Coronavirus - leading candidates
RELATED RESOURCES
with chunks in common
2020
Can the world find a good covid-19 vaccine quickly enough?
Saved by: FoundryBase
used in 1 chunk
2020
The race for coronavirus vaccines: a graphical guide - Nature (April 2020)
Saved by: FoundryBase
used in 1 chunk
2020
What you need to know about the COVID-19 vaccine | Bill Gates
Saved by: FoundryBase
used in 2 chunks
2020
Moderna reports positive data on early-stage coronavirus vaccine trial, shares surge
Saved by: FoundryBase
used in 1 chunk
2020
Pivotal testing for coronavirus vaccines to start this summer — The Wall Street Journal
Saved by: FoundryBase
used in 2 chunks
2020
The Graphic Truth: Competing and cooperating on a COVID-19 vaccine
Saved by: FoundryBase
used in 1 chunk
2020
Moderna's Vaccine Candidate Heads To Testing In Up To 30,000 People : Coronavirus Live Updates
Saved by: FoundryBase
used in 1 chunk
2020
Synthetic biologists have created a slow-growing version of the coronavirus to give as a vaccine
Saved by: FoundryBase
used in 1 chunk
2020
The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Saved by: FoundryBase
used in 2 chunks
MORE RELATED CONTENT
with shared categories
2021
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
Saved by: FoundryBase
used in 1 chunk
2021
Personalized Skin Cancer Vaccine Shows Promise in New Trial Results
Saved by: FoundryBase
used in 4 chunks
2020
The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Saved by: FoundryBase
used in 2 chunks
2020
Why Oxford’s positive COVID vaccine results are puzzling scientists
Saved by: FoundryBase
used in 1 chunk
2020
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
Saved by: FoundryBase
used in 1 chunk
2020
The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug
Saved by: FoundryBase
used in 1 chunk
2020
Nature: The race to make COVID antibody therapies cheaper and more potent (Oct. 2020)
Saved by: FoundryBase
used in 2 chunks
2020
Remdesivir has ‘little or no effect’ in reducing coronavirus deaths, WHO says
Saved by: FoundryBase
used in 1 chunk
2020
U.S. pauses Eli Lilly's trial of a coronavirus antibody treatment over safety concerns
Saved by: FoundryBase
used in 1 chunk
2020
Remdesivir Makes It Harder For Coronavirus To Spread Within The Body
Saved by: FoundryBase
used in 1 chunk
No comments yet. Be the first to comment!